The largest database of trusted experimental protocols

Xl1 blue supercompetent cells

Manufactured by Agilent Technologies
Sourced in United States

XL1-Blue supercompetent cells are a strain of genetically engineered Escherichia coli (E. coli) bacteria commonly used in molecular biology experiments. They are designed to have enhanced competence, allowing for efficient uptake and transformation of DNA plasmids during genetic engineering procedures.

Automatically generated - may contain errors

20 protocols using xl1 blue supercompetent cells

1

Site-Directed Mutagenesis of SP1 Expression Vector

Check if the same lab product or an alternative is used in the 5 most similar protocols
An SP1 expression vector (pLXSN-SP1) was expanded in DH5α competent cells and used as a template to create the SP1 mutants using the QuikChange II site-directed mutagenesis kit (Agilent Technologies), according to the manufacturer’s instructions. Briefly, to generate the K19R mutation, mutagenic primers (Eurofin) were designed using the Quick-Change Primer Design Program (Agilent Technologies). The first step of the site-directed mutagenesis involved mutant-strand synthesis by PCR using the mutagenic primers, following which the amplified products were treated with DpnI at 37 °C for 1 h to digest the parental methylated and hemimethylated DNA template. The newly synthesized mutated DNA was transformed into XL1-blue super competent cells (Agilent Technologies) for selection of the mutated SP1 clones.
+ Open protocol
+ Expand
2

GUCY2C Expression Vector Construction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Expression vectors pcDNA3.1(+) containing full GUCY2C cDNA sequence with and without the c.2381A > T variant were constructed by BioMatik (BioMatik, Ontario, Canada). Vectors were treated with NotI and AflII restriction enzymes (New England BioLabs, Ipswich, MA) and inserts were gel purified using the Zymoclean Gel DNA recovery kit (ZymoResearch, Irvine, CA), then ligated into the multicloning site of a pcDNA3.1(+) IRES‐GFP expression vector (Addgene, Watertown, MA). The ligation product was introduced into XL‐1 Blue supercompetent cells (Agilent, Santa Clara, CA), and Sanger sequencing was used to confirm the full GUCY2C insert sequence (Supplementary Table S1).
+ Open protocol
+ Expand
3

Mutagenesis and Protein Expression of bfrB

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pET11a vector containing the bfrB gene (16 (link)) was mutated to D34F, N148L, Q151L and C89SK96C using the QuikChange II Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA) using the manufacturer instructions. Primer pair sequences are provided in Supplementary Information. PCR products were digested using Dpn I and transformed into XL1-Blue Supercompetent cells (Agilent Technologies) for DNA amplification. Plasmid DNA was isolated using the QIAprep Spin Miniprep Kit (QIAGEN), and the sequences verified by SeqWright (Houston, TX). Recombinant DNA plasmids with the correct sequence were transformed to Escherichia coli ArcticExpress (DE3)RIL competent cells (Agilent Technologies) for subsequent protein expression. The protocols for protein expression, purification and reconstitution with heme have been described previously (16 (link), 21 (link)).
+ Open protocol
+ Expand
4

Site-Directed Mutagenesis of proA Alleles

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wild-type proA alleles from each strain were changed to introduce a codon for Ala at a position corresponding to E383 in the E. coli enzyme using the QuikChange protocol (Agilent). The products were digested by DpnI, and the plasmids were introduced into XL1-Blue Supercompetent cells (Agilent). The cells were plated on LB agar containing 50 µg/ml ampicillin and grown overnight at 37°C. The introduction of the intended mutation was verified by sequencing purified plasmid DNA.
+ Open protocol
+ Expand
5

Cloning and Expression of EMV CP Gene

Check if the same lab product or an alternative is used in the 5 most similar protocols
The sequence of the EMV CP gene (wtEMV; GenBank Accession Number: NC_001480.1) was obtained as a product of gene synthesis (plasmid pUC57-EMV; BioCat, Heidelberg, Germany) with flanking restriction sites NdeI and XhoI for further subcloning. The wtEMV CP gene was excised from the helper plasmid with NdeI and XhoI restriction enzymes (Thermo Fisher Scientific, Waltham, MA, USA), followed by DNA fragment purification with the GeneJET Gel Extraction Kit (Thermo Fisher Scientific, Waltham, MA, USA) and cloning into the NdeI and XhoI sites of the E. coli expression vector pET42a(+) (Novagen, Madison, WI, USA), resulting in the pET42-EMV expression vector. XL1-Blue Super competent cells (Agilent Technologies, Santa Clara, CA, USA) were used for plasmid preparations. Clones with the corresponding insert were selected by restriction analysis by digestion with NdeI and XhoI.
+ Open protocol
+ Expand
6

Recombinant Protein Expression in CHO Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Polyoma large T antigen- expressing Chinese hamster ovary (CHOP) cells were a gift from James W. Dennis (Samuel Lunenfeld Research Institute, Toronto, Canada); Bombesin receptor subtype-3 antagonist (Bantag-1) was gifts from Merck, Sharp and Dohme (West Point, PA); the mammalian expression vectors, pcDNA3, custom primers were from Invitrogen (Carlsbad, CA); QuikChange Site-Directed Mutagenesis Kit was from Agilent Technologies (Santa Clara, CA); cDNA of hBB3 receptor, mBB2 receptor and mBB1 receptor were obtained as described previously[40 (link)–42 (link)]; Dulbecco’s minimum essential medium (DMEM), phosphate-buffered saline (PBS), G418 sulfate, fetal bovine serum (FBS), penicillin, streptomycin and sodium pyruvate from Gibco Life Technology (Grand Island, NY); DpnI, Phusion® HF DNA Polymerase, dNTP, 100 % DMSO and 5X Phusion HF (GC) Buffer were from New England Biolabs (Ipswich, MA); formic acid, ammonium formate, disodium tetraborate, and alumina were obtained from Sigma-Aldrich (St. Louis, MO); iodine- 125 (100 mCi/ml) was from Perkin Elmer Life Sciences (Boston, MA); Polyethylenimine lipofectamine (P.E.I) (lipofectamine) was from Polysciences, Inc. (Warrington, PA); Standard protected amino acids and other synthetic reagents were obtained from Bachem Bioscience Inc. (King of Prussia, PA); XL1-Blue Supercompetent Cells from Agilent Technologies (Santa Clara, CA).
+ Open protocol
+ Expand
7

Plasmid Amplification and Mutagenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmids were amplified by transformation into XL1-Blue supercompetent cells (Agilent Technologies) by following manufacturer’s instructions. Bacteria was then grown overnight in 5 mL cultures in LB media with respective selectable marker antibiotic. Plasmids were then isolated using ZymoPURE plasmid mini-prep kit by following manufacturer’s instructions. Plasmid concentrations were determined via absorbance at 260 nm using a Nanodrop 2000 device (Thermo Scientific). Site directed mutagenesis was performed on pcDNA3.1-Myc-eIF4A1 by using the Quick-change Site Directed mutagenesis kit (Agilent Technologies) according to manufacturer’s instructions. Mutations were verified via commercial sanger sequencing (Genewiz).
+ Open protocol
+ Expand
8

Synthesis and Purification of Bacterial Cofactor

Check if the same lab product or an alternative is used in the 5 most similar protocols
Buffer salts were
purchased from
Research Products International Corp. (RPI) and used without further
purification. All crystallization materials were from Hampton Research.
Metals were obtained as their chloride salts from J. T. Baker. l-Cysteine was purchased from Sigma Life Sciences. Fosfomycin
disodium salt was from MP Biomedicals, LLC. BSH was synthesized as
bacillithiol disulfide (BSSB) by the Vanderbilt Chemical Synthesis
Core and reduced to BSH prior to use according to published procedures.19 (link) pET28 (FosBSa) was
from Platinum PCR SuperMix, and custom primers were ordered from Invitrogen
(Carlsbad, CA). Restriction enzymes were from New England Biolabs
(Ipswich, MA). The pET20b(+) vector was from EMB Chemicals, Inc. (Gibbstown,
NJ). XL1-Blue supercompetent cells and BL21-Gold (DE3) cells were
from Agilent Technologies (Santa Clara, CA).
+ Open protocol
+ Expand
9

Cloning Fluorescent Protein-Receptor Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
pHmystik-pRK7 was a gift from M. Aurousseau and D. Bowie (Aurousseau, 2015 ). pHmystik generates a monomeric fluorescent protein that fluoresces in the blue-green spectrum. Purified pHmystik-pRK7 DNA was isolated via Mini Prep (QIAGEN) and confirmed by sequencing. Nhe1 restriction enzyme cloning sites were introduced via site-directed mutagenesis into GluN1 and GluN2A after the fourth amino acid of the mature protein (not including signal peptide). Nhe1 restriction enzyme sites were introduced at the 5′ and 3′ ends of the pHmystik insert in the pRK7 backbone. pHmystik-5′,3′ Nhe1, GluN1-Nhe1, and GluN2A-Nhe1 constructs were digested with Nhe1 in the presence of BSA, dephosphorylated with rSAP (NEB M0371S) and then separated on 0.8% agarose gel (1× TAE). Digested pHmystik and linearized GluN1 and GluN2A were extracted via Zymoclean gel-purification (Zymo D4001S). Purified pHmystik was inserted into the vector, with either GluN1 or GluN2A, using Roche rapid DNA ligation kit (04898117001; Roche). Ligation reaction of pHmystik-GluN1 and pHmystik-GluN2A was transformed into XL1-Blue super-competent cells (Agilent Technologies), and isolated colonies were picked for Mini Prep. Purified DNA of desired constructs were confirmed by DNA sequencing.
+ Open protocol
+ Expand
10

Purification and Characterization of FosB Enzyme

Check if the same lab product or an alternative is used in the 5 most similar protocols
Buffer salts were purchased from Research Products International Corp. (RPI) and used without further purification. All crystallization materials were from Hampton Research. Metals were obtained as their chloride salts from J. T. Baker. L-Cysteine was purchased from Sigma Life Sciences. Fosfomycin disodium salt was from MP Biomedicals, LLC. BSH was synthesized as bacillithiol disulfide (BSSB) by the Vanderbilt Chemical Synthesis Core and reduced to BSH prior to use according to published procedures.19 (link) pET28 (FosBSa) was from Platinum PCR SuperMix, and custom primers were ordered from Invitrogen (Carlsbad, CA). Restriction enzymes were from New England Biolabs (Ipswich, MA). The pET20b(+) vector was from EMB Chemicals, Inc. (Gibbstown, NJ). XL1-Blue supercompetent cells and BL21-Gold (DE3) cells were from Agilent Technologies (Santa Clara, CA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!